Interaction of pHPMA-pLMA copolymers with human blood serum and its components

Molecular Pharmaceutics

Volumn 10, Issue 10, 2013, Pages 3769-3775

  Hemmelmann, Mirjam ^a   Mohr, Kristin ^a   Fischer, Karl ^a   Zentel, Rudolf ^a   Schmidt, Manfred ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Amphiphilic copolymers; Blood polymer interactions; Dynamic light scattering; HPMA based copolymers; Human serum; Polymer therapeutics; Protein polymer complex

Indexed keywords

AMPHOPHILE; COPOLYMER; DOMPERIDONE; LAURYL METHACRYLATE; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TRANSPORT; ENCAPSULATION; HUMAN; HYDRODYNAMICS; HYDROPHOBICITY; LIGHT SCATTERING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SERUM;

HUMANS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MICELLES; POLYMERS;

EID: 84888384542     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400254b     Document Type: Article

References (24)

1. Ferrari, M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5 (3), 161-71.
2. Zolnik, B. S.; Sadrieh, N. Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs. Adv. Drug Delivery Rev. 2009, 61 (6), 422-7.
3. Ringsdorf, H. Structure and properties of pharmacologically active polymers. J. Polym. Sci. 1975, 51, 135-153.
4. Duncan, R. Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer 2006, 6 (9), 688-701.
5. Markovsky, E.; Baabur-Cohen, H.; Eldar-Boock, A.; Omer, L.; Tiram, G.; Ferber, S.; Ofek, P.; Polyak, D.; Scomparin, A.; Satchi-Fainaro, R. Administration, distribution, metabolism and elimination of polymer therapeutics. J. Controlled Release 2012, 161 (2), 446-60.
6. Walkey, C. D.; Chan, W. C. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev. 2012, 41 (7), 2780-99.
7. Takakura, Y.; Hashida, M. Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution. Pharm. Res. 1996, 13 (6), 820-31.
8. Haag, R.; Kratz, F. Polymer therapeutics: concepts and applications. Angew. Chem., Int. Ed. 2006, 45 (8), 1198-215.
9. Seymour, L. W.; Duncan, R.; Strohalm, J.; Kopecek, J. Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J. Biomed. Mater. Res. 1987, 21 (11), 1341-58.
10. Xue, W. Interactions between solubilized polymer molecules and blood components. J. Controlled Release 2012, 160, 14-24.
11. Aggarwal, P.; Hall, J. B.; McLeland, C. B.; Dobrovolskaia, M. A.; McNeil, S. E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Delivery Rev. 2009, 61 (6), 428-37.
12. Rausch, K.; Reuter, A.; Fischer, K.; Schmidt, M. Evaluation of Nanoparticle Aggregation in Human Blood Serum. Biomacromolecules 2010, 11 (11), 2836-9.
13. Kreuter, J. Nanoparticulate systems for brain delivery of drugs. Adv. Drug Delivery Rev. 2001, 47 (1), 65-81.
14. Gessner, A.; Olbrich, C.; Schroder, W.; Kayser, O.; Muller, R. H. The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. Int. J. Pharm. 2001, 214 (1-2), 87-91.
15. Barz, M.; Tarantola, M.; Fischer, K.; Schmidt, M.; Luxenhofer, R.; Janshoff, A.; Theato, P.; Zentel, R. From defined reactive diblock copolymers to functional HPMA-based self-assembled nanoaggregates. Biomacromolecules 2008, 9 (11), 3114-8.
16. Barz, M.; Luxenhofer, R.; Zentel, R.; Kabanov, A. V. The uptake of N-(2-hydroxypropyl)-methacrylamide based homo, random and block copolymers by human multi-drug resistant breast adenocarcinoma cells. Biomaterials 2009, 30 (29), 5682-90.
17. Hemmelmann, M.; Metz, V. V.; Koynov, K.; Blank, K.; Postina, R.; Zentel, R. Amphiphilic HPMA-LMA copolymers increase the transport of Rhodamine 123 across a BBB model without harming its barrier integrity. J. Controlled Release 2012, 163 (2), 170-7.
18. Hemmelmann, M.; Knoth, C.; Schmitt, U.; Allmeroth, M.; Moderegger, D.; Barz, M.; Koynov, K.; Hiemke, C.; Rosch, F.; Zentel, R. HPMA based amphiphilic copolymers mediate central nervous effects of domperidone. Macromol. Rapid Commun. 2011, 32 (9-10), 712-7.
19. Havel, R. J.; Eder, H. A.; Bragdon, J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34 (9), 1345-53.
20. Hemmelmann, M.; Kurzbach, D.; Koynov, K.; Hinderberger, D.; Zentel, R. Aggregation Behavior of Amphiphilic p(HPMA)-cop(LMA) Copolymers Studied by FCS and EPR Spectroscopy. Biomacromolecules 2012, 13, 4065-74.
21. Klajnert, B.; Stanislawska, L.; Bryszewska, M.; Palecz, B. Interactions between PAMAM dendrimers and bovine serum albumin. Biochim. Biophys. Acta 2003, 1648 (1-2), 115-26.
22. Audobert, P. Association between hydrophobically modified polyanions and negatively charged bovine serum albumine. J. Phys. Chem. B 1998, 102, 1327-1333.
23. Asadi, A.; Saboury, A. A.; Moosavi-Movahedi, A. A.; Divsalar, A.; Sarbolouki, M. N. Interaction of bovine serum albumin with some novel PEG-containing diblock copolymers. Int. J. Biol. Macromol. 2008, 43 (3), 262-70.
24. Wasan, K. M.; Brocks, D. R.; Lee, S. D.; Sachs-Barrable, K.; Thornton, S. J. Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery. Nat. Rev. Drug Discovery 2008, 7 (1), 84-99.